Christina (Tina) P./LinkedIn
Jun 21, 2026, 14:38
Christina (Tina) P: Staying Safe on Anticoagulation Therapy in Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Bleeding Risks and Blood Thinners: APS Awareness Day 21
Blood thinners (also called anticoagulants) are medicines that prevent blood clots.
They’re often used in conditions like Antiphospholipid Syndrome (APS) to reduce the risk of strokes, deep vein thrombosis (DVT), and other clot-related issues.
Blood thinners save lives by preventing dangerous clots — but they must be taken carefully to avoid serious bleeding.
Knowing the risks helps you stay safe and prepared.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics